Celldex Therapeutics News

Celldex Therapeutics Analyst Ratings

BenzingaMay 15 10:39 ET

Celldex Therapeutics Analyst Ratings

BenzingaMay 7 06:53 ET

Celldex Therapeutics Analyst Ratings

BenzingaApr 17 10:34 ET

Celldex Therapeutics Analyst Ratings

BenzingaMar 22 13:50 ET

Cantor Fitzgerald Reiterates Overweight on Celldex Therapeutics, Maintains $67 Price Target

BenzingaMar 22 13:51 ET

Celldex Therapeutics Analyst Ratings

BenzingaFeb 27 12:03 ET

Celldex Therapeutics Analyst Ratings

BenzingaDec 20, 2023 08:32 ET

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

BenzingaNov 10, 2023 06:27 ET

Celldex Therapeutics Analyst Ratings

BenzingaNov 10, 2023 06:25 ET

HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $80

BenzingaNov 6, 2023 11:09 ET

Celldex Therapeutics Analyst Ratings

BenzingaNov 6, 2023 11:07 ET

Celldex (CLDX) Gets a Buy From Cantor Fitzgerald

TipRanksNov 6, 2023 08:01 ET

Cantor Fitzgerald Maintains Overweight on Celldex Therapeutics, Lowers Price Target to $52

BenzingaNov 3, 2023 12:49 ET

Celldex Therapeutics Analyst Ratings

BenzingaNov 3, 2023 12:48 ET

Cantor Fitzgerald Reiterates Overweight on Celldex Therapeutics, Maintains $54 Price Target

BenzingaOct 12, 2023 11:52 ET

Celldex Therapeutics Analyst Ratings

BenzingaOct 12, 2023 11:51 ET

Cantor Fitzgerald Reiterates Overweight on Celldex Therapeutics, Maintains $54 Price Target

BenzingaSep 27, 2023 08:56 ET

Celldex Therapeutics Analyst Ratings

BenzingaSep 27, 2023 08:54 ET

Celldex Therapeutics Analyst Ratings

BenzingaAug 22, 2023 06:49 ET

Cantor Fitzgerald Reiterates Overweight on Celldex Therapeutics, Maintains $54 Price Target

BenzingaAug 16, 2023 09:32 ET